DynaVox Announces Management and Board Changes PITTSBURGH,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DynaVox Announces Management and Board Changes

PITTSBURGH, March 27, 2014 (GLOBE NEWSWIRE) -- DynaVox Systems, LLC ("DynaVox"), the world's leading provider of communication and education products for individuals with significant speech, language and learning disabilities, today announced that JEC Capital Partners, LLC ("JEC") and Fondren Management, LP have acquired its senior debt and have replaced all members of the Board of Directors of DynaVox. The senior debt is held by a newly formed entity called JEC-BR Partners, LLC.

The new Board of DynaVox has appointed Derek Harrar as Interim Chief Executive Officer, replacing Michelle Heying-Wilver.

Mr. Harrar stated, "I look forward to working with my colleagues at DynaVox, fulfilling our mission of transforming the lives of our customers through continued innovation. The Company is at an exciting stage, with a strong pipeline of new products, which build on the recent, successful launch of the DynaVox T10. Our new products will be introduced over the next few months and they are specifically aimed at helping our customers in both the speech-generating device and education markets. I am confident that our new financial partners will provide DynaVox with the leadership and capital to profitably grow and maintain our position as the world leader in communication and educational products."

Speaking on behalf of JEC Capital Partners and the Board, Michael Torok said, "In the past few weeks, we have made a few difficult, but necessary changes to position DynaVox to grow and prosper. We believe that Derek is the right person to step in and, together with the existing leadership team, help make key decisions that serve the common interests of our customers and employees. In addition to the launch of the T10 and the strong pipeline of products, DynaVox has a passionate and dedicated employee base, focused on delivering world-class solutions to our customers.  We are committed to DynaVox and we are excited about the future and prospects of the Company. " 

Bob Cunningham, Chief Strategy Officer at DynaVox, added: "We at DynaVox consider ourselves privileged to continue to serve our outstanding customers with the very best augmentative communication and educational products and services. With a fresh start and strong leadership, we look forward to accelerating the development and launch of several new products."

About DynaVox Systems, LLC

DynaVox Systems, LLC, is the leading provider of speech generating devices and symbol-adapted special education software used to assist individuals in overcoming their speech, language and learning challenges. These solutions are designed to help individuals who have complex communication and learning needs participate in the home, classroom and community. Our mission is to enable our customers to realize their full communication and education potential by developing industry-leading devices, software and content and by providing the services to support them. We assist individuals, families, and professionals with an extensive field support organization, as well as centralized technical and reimbursement support. For more information, visit www.dynavoxtech.com .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Radiation Oncology Text Earns Doody's 2026 Nod

Updated Category News Views 24

Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...

Continue Reading
Curis Prepares for Q3 2026 Results Amid Tough Sector Trends

Updated Category News Views 139

All Eyes on Curis as Q3 Financials Loom Just when you think you’ve seen it all in this wild biotech ride, Curis, Inc. (NASDAQ: CRIS) is prepping to roll out their third quarter financial and operating results. Circle your calendars for November 12, 2026, because the clock’s ticking down to their 4:00 p.m. ET announcement, swiftly followed by a conference call at 4:30...

Continue Reading
Home Insurance Depreciation and What it Means for You

Updated Category News Views 17

A Deep Dive into Depreciation's Impact on Home Insurance Folks, if you haven't battled the insurance beast, you're missing out on an unholy mess. Let's talk about something that's been quietly gnawing at homeowners’ wallets—depreciation in home insurance claims. Peggy Schneider, an insurance guru from Kalispell, Montana, lays it all out in HelloNation, and I'm here to...

Continue Reading
FDA Greenlights Halozyme's Cancer Treatment Breakthrough

Updated Category News Views 18

FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...

Continue Reading
Birth Registration Revolution: OSIA Interoperability Demo

Updated Category News Views 86

Bringing Birth Registration into the 21st Century Alright, let's cut through the fog. If you ask most folks about their birth certificates, you'd hear tales of tattered paper and government office runs. What if I told you this vital piece of paper could be reborn altogether? That's what the Secure Identity Alliance is up to with their OSIA Live Interoperability Demo at...

Continue Reading
TELUS Boosts Board with Strategic Executive Appointments

Updated Category News Views 47

New Faces on the TELUS Board: Shaping the Future Alright, investors, here's the scoop straight from the trenches: TELUS (TSX:TU) is shaking things up at the top. Marc Allera and Bill Thomas are stepping into the fray as the newest members of the board, effective January 1, 2027. If you're not familiar with these names, it's time to tune in because they've got the chops to...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 68

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Bowling Makes a Strike at Macy's 100th Parade in NYC

Updated Category News Views 64

Rolling with Tradition: Bowling at Macy's Parade Back in the day, bowling wasn't exactly the sport making headlines. But times, they change. Here we are in the thick of things, witnessing Go Bowling getting its moment in the spotlight during the historic 100th Macy's Thanksgiving Day Parade®. It's not about raking in the dough or hitting some stocks; it’s about...

Continue Reading
PPL Reports Strong Q3; Long-Term EPS Growth Up

Updated Category News Views 29

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

Continue Reading
Tucows Shows Progress in Q3 2026 Amidst Net Loss

Updated Category News Views 140

Q3 Snapshot: Balancing Act at Tucows Man, if there's one thing you can count on from Tucows, it's that they'll shuffle the deck just when you're getting comfortable. Here in the third quarter of 2026, they've managed a decent juggling act. Their unaudited numbers show consolidated net revenue ticking up 1.4% from last year, rounding out at a cool $100 million. That's...

Continue Reading

Top 5 Most Recently Viewed Articles

Nicole Kidman's New Role as Clé de Peau Beauté Ambassador

Updated Category News Views 302

Nicole Kidman Joins Clé de Peau Beauté as Global Brand Ambassador The renowned and celebrated Hollywood actress, Nicole Kidman, has taken on a monumental role as the new Global Brand Ambassador for Clé de Peau Beauté, a brand recognized for its luxurious skincare and makeup offerings. Kidman's exceptional presence in the entertainment industry transcends mere stardom;...

Continue Reading
Future FinTech Group Unveils Innovative AI Trading Platform

Updated Category News Views 171

Future FinTech Group Launches AI-Powered Trading Platform Future FinTech Group Inc. (NASDAQ: FTFT), known for its comprehensive financial and digital technology services, has initiated an exciting endeavor with its subsidiary, FTFT International Securities & Futures Co., Ltd. ("Future Securities"). This strategic move aims to revolutionize investment analytics and trading...

Continue Reading
GardaWorld Finalizes Successful Credit Facility Enhancements

Updated Category News Views 124

GardaWorld's Strategic Credit Facility Enhancements MONTREAL / -- Garda World Security Corporation, known as GardaWorld, is making significant strides in its operational efficiency and financial management. This entrepreneurial-driven company specializes in security services and innovative risk solutions. Recently, GardaWorld has successfully completed amendments to its...

Continue Reading
Transformative Trends in eCommerce: The Future of Marketing

Updated Category News Views 361

Understanding the Future of eCommerce Marketing As we approach a pivotal moment in the eCommerce realm, it's essential to recognize the trends that are not only shaping the industry today but are also setting the stage for 2025. The digital marketplace is evolving rapidly, and organizations must adapt to thrive. Based on insights shared by leading experts, including CEO...

Continue Reading
OSE Immunotherapeutics Reveals Strategic Innovations for Growth

Updated Category News Views 238

OSE Immunotherapeutics Shapes Future with 2026-2028 Strategic Vision OSE Immunotherapeutics has unveiled an ambitious strategic plan aimed at enhancing its product offerings and maximizing shareholder value. This plan is designed for the upcoming three years and spans innovative treatments and strategic initiatives that promise to propel the company forward in the...

Continue Reading